{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:51:44Z","timestamp":1790009504600,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.diagmicrobio.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T02:46:41Z","timestamp":1456022801000},"page":"233-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?"],"prefix":"10.1016","volume":"85","author":[{"given":"Yasemin","family":"Ozsurekci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Aykac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bulent","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihangul","family":"Bayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Sancak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda Karadag","family":"Oncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ates","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2047-2994-2-31","article-title":"Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum","volume":"2","author":"Huttner","year":"2013","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0015","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10156-007-0557-0","article-title":"Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic","volume":"13","author":"Brahmi","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1592\/phco.28.2.235","article-title":"The current state of multidrug-resistant gram-negative bacilli in North America","volume":"28","author":"Nicasio","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3947\/ic.2014.46.3.149","article-title":"Therapy of infections due to carbapenem-resistant Gram-negative pathogens","volume":"46","author":"Lee","year":"2014","journal-title":"Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pundrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0035","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.50.5.1715-1720.2006","article-title":"Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae","volume":"50","author":"Anderson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","article-title":"Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship","volume":"49","author":"Roberts","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0045","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jac\/dku168","article-title":"Combination therapy for carbapenem-resistant Gram-negative bacteria","volume":"69","author":"Paul","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1469-0691.2011.03734.x","article-title":"Colistin: new lessons on an old antibiotic","volume":"18","author":"Yahav","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/INF.0b013e31818a5dbd","article-title":"Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis","volume":"28","author":"Falagas","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0060","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","article-title":"Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections","volume":"12","author":"Falagas","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0065","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0070","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","article-title":"Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis","volume":"49","author":"Kasiakou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0080","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ijantimicag.2008.10.021","article-title":"Systemic colistin use in children without cystic fibrosis: a systematic review of the literature","volume":"33","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0085","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/INF.0000000000000117","article-title":"The use of colistin in critically ill children in a pediatric intensive care unit","volume":"33","author":"Karbuz","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-0711-12-32","article-title":"Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital","volume":"12","author":"Karli","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2009.11.016","article-title":"Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections","volume":"35","author":"Cheng","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BCR.0b013e3181abffb6","article-title":"The use of colistin in a pediatric burn unit in Argentina","volume":"30","author":"Rosanova","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1998","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0115","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0120","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/AAC.01015-06","article-title":"Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients","volume":"51","author":"Hachem","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijantimicag.2006.07.008","article-title":"Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU","volume":"28","author":"Kallel","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s00134-005-2691-4","article-title":"Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study","volume":"31","author":"Reina","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1592\/phco.31.12.1257","article-title":"Nephrotoxicity associated with intravenous colistin in critically ill patients","volume":"31","author":"Doshi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jinf.2008.04.002","article-title":"Efficacy and safety of high-dose ampicillin\/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"56","author":"Betrosian","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijantimicag.2007.05.017","article-title":"Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"30","author":"Furtado","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0160","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.47.8.2659-2662.2003","article-title":"Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria","volume":"47","author":"Ouderkirk","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1155\/2007\/673976","article-title":"Comparative effectiveness of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis","volume":"14","author":"Brochet","year":"2007","journal-title":"Can Respir J"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0170","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/adc.84.5.432","article-title":"Bronchoconstriction following nebulised colistin in cystic fibrosis","volume":"84","author":"Cunningham","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijantimicag.2012.04.010","article-title":"Old agent, new experience: colistin use in the paediatric Intensive Care Unit-a multicentre study","volume":"40","author":"Paksu","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/1469-0691.12363","article-title":"Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis","volume":"20","author":"Lemos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.diagmicrobio.2012.12.012","article-title":"Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program","volume":"75","author":"Morrow","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0195","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","article-title":"Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections","volume":"33","author":"Batirel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.diagmicrobio.2016.02.017_bb0200","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/BCR.0B013E318053D346","article-title":"Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population","volume":"28","author":"Goverman","year":"2007","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-200X.2009.03015.x","article-title":"Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients","volume":"52","author":"Celebi","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.diagmicrobio.2016.02.017_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijantimicag.2014.12.002","article-title":"Increased risk of nephrotoxicity: Side effect of colistin use in paediatric patients","volume":"45","author":"Ozkaya-Parlakay","year":"2015","journal-title":"Int J Antimicrob Agents"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931630030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931630030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:55:46Z","timestamp":1536972946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931630030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S073288931630030X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.02.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}